New strategies for the management of AIDS-related CMV retinitis in the era of potent antiretroviral therapy

Ocular Immunology and Inflammation

Volumn 7, Issue 3-4, 1999, Pages 179-188

  Holland, Gary N ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

Antiretroviral drug; Antiviral drug; Cytomegalovirus retinitis; Treatment

Indexed keywords

ANTIRETROVIRUS AGENT; CIDOFOVIR; FOMIVIRSEN; FOSCARNET; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; HUMAN; RETINITIS;

EID: 0033372714     PISSN: 09273948     EISSN: None     Source Type: Journal    
DOI: 10.1076/ocii.7.3.179.4000     Document Type: Conference Paper

References (28)

1. 1 Palella F, Delaney K, Moorman A, Loveless M, Fuhrer J, Satten G, Aschman R, Holmberg S. Declining morbidity and mortality among patients with advanced human immunodefeciency virus infection. N Engl J Med 1998;338:853-860.
2. 2 Walsh J, Jones C, Barnes E, Gazzard B, Mitchell S. Increasing survival in AIDS patients with cytomegalovirus retinitis treated with combination antiretroviral therapy including HIV protease inhibitors. AIDS 1998;12: 613-618.
3. 3 Kuppermann BD, Flores-Aguilar M, Quiceno JI, et al. Correlation between CD4+ T-lymphocyte counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1993;115:575-582.
4. 4 Jacobson MA, Zegans M, Pavan PR, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997; 349:1443-1445.
5. 5 Jabs DA, Enger C, Dunn JP, Forman M. Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. J Infect Dis 1998;177:770-773.
6. 6 Liu W, Kupperman B, Martin D, Wolitz R, Margolis T. Mutations in the cytomegalovirus UL97 gene associated with ganiclovir-resistant retinitis. J Infect Dis 1998;177;1176-1181.
7. 7 Jabs D, Enger C, Dunn JP, Forman M, Hubbard L. Cytomegalovirus retinitis and viral resistance. 3. Culture results. Am J Ophthalmol 1998;126: 543-549.
8. 8 Jabs DA, Bartlett JG. AIDS and ophthalmology: a period of transition. Am J Ophthalmol 1997;124:227-233.
9. 9 Martin DE, Kuppermann B D, Wolitz RA, et al. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. N Engl J Med 1999;340: 1063-1070.
10. 10 Holland GN, Tufail A, Jordan C. Cytomegalovirus diseases. In: Pepose JS, Holland GN, Wilhelmus, KR, editors. Ocular Infection & Immunity. St. Louis: C.V. Mosby Co., 1996; 1088-1129.
11. 11 Reed JB, Schwab IR, Gordon J, Morse LS. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS. Am J Ophthalmol 1997;124:199-205.
12. 12 Whitcup SM, Cunningham ET, Polis MA, Fortin E. Spontaneous and sustained resolution of CMV retinitis in patients receiving highly active antiretroviral therapy. Br J Ophthalmol 1998;82:845-846.
13. 13 Davis JL, Tabandeh H, Feuer WJ, Kumbhat S, Roth DB, Chaudry NA. Effect of potent antiretroviral therapy on recurrent cytomegalovirus retinitis treated with the ganciclovir implant. Am J Ophthalmol 1999;127:283-287.
14. 14 Martin DF, Dunn JP, Davis JL, et al. Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: recommendations of an International AIDS Society - USA panel. Am J Ophthalmol 1999;127: 329-339.
15. 15 Lim JI, Wolitz RA, Dowling AH, et al. Visual and anatomic outcomes associated with posterior segment complications following ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol 1999;127:288-293.
16. 16 Siegner SW, Holland GN, Stempien MJ, Crager M, Robinson CA, Hubbard L. The relationship between CMV retinitis activity at the start of maintenance therapy and time to progression. Invest Ophthalmol Vis Sci 1997;38(Suppl):S915.
17. 17 Macdonald JC, Torriani FJ, Morse LS, et al. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. J Infect Dis 1998;177:1182-1187.
18. 18 Whitcup SM, Fortin E, Nussenblatt RB, et al. Therapeutic effect of combination antiretroviral therapy on cytomegalovirus retinitis (letter). J Am Med Assoc 1997;277:1519-1520.
19. 19 Tural C, Romeu J, Sirera G, et al. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients. J Infect Dis 1998;177:1080-1083.
20. 20 Vrabec TR, Baldassano VF, Whitcup SM. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts. Ophthalmology 1998; 105:1259-1264.
21. 21 Jabs DA, Bolton SF, Dunn JP, Palestine AG. Discontinuing anti-CMV therapy in patients with immune reconstitution after combination antiretroviral therapy. Am J Ophthalmol 1998;126:817-822.
22. 22 Nolan W, Mitchell S. Do all patients with CVM-retinitis require life long anti-CMV therapy? Br J Ophthalmol 1998;82:844-845.
23. 23 Komanduri KV, Viswanathan MN, Wieder ED, et al. Restoration of cytomegalovirus-specific CD4 T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat Med 1998; 4:953-956.
24. 24 Bowen EF, Sabin CA, Wilson P, et al. Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease. AIDS 1997;11:889-893.
25. 25 Dodt KK, Jacobsen PH, Hofmann B, et al. Development of cytomegalovirus (CMV) disease may be predicted by HIV-infected patients by CMV polymerase chain reaction and the antigenemia test. AIDS 1997;11:F21-F28.
26. 26 Spector SA, Wong R, Hsia K, et al. Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survivial in AIDS patients. J Clin Invest 1998;101:497-502.
27. 27 Tufail A, Moe A, Bruckner DA, et al. Quantitative cytomegalovirus (CMV) DNA load in the blood and its relationship to CMV retinitis in patients with AIDS. Ophthalmology 1999;106:133-141.
28. 28 Bowen EF, Emery VC, Wilson P, et al. Cytomegalovirus polymerase chain reaction viraemia in patients receiving ganciclovir maintenance therapy for retinitis. AIDS 1998;12: 605-611.